Peptide Programs
Selank
An investigational peptide listing with no anxiety, mood, or mental-health treatment claims.
$149/month
All-inclusive program price · Illustrative demonstration pricing
Product. Product imagery is an illustrative demonstration mock-up; labels, lots, and concentrations shown are not real.
Peptide Programs
Semax Program
An investigational peptide shown for demonstration only. ClientRx makes no cognitive, neurological, or psychiatric claims.
$149/month
All-inclusive program price · Illustrative demonstration pricing
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
Investigational — not FDA-approved
Illustrative demonstration presentation only
Demonstration only. Not available for prescribing or fulfilment.
Purchasing a program does not guarantee that a prescription will be issued. If the provider does not approve treatment, the order will be handled according to the ClientRx refund and cancellation policy. Laboratory testing, expedited shipping, replacement products, and third-party services are not included unless specifically stated.
Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.
About this program
Semax is included in the ClientRx demonstration catalogue to represent investigational peptides frequently marketed with cognitive or neurological claims.
Semax is a synthetic peptide developed and used in certain jurisdictions outside the United States. It is not an FDA-approved drug product in the United States.
ClientRx does not claim that Semax treats stroke, cognitive impairment, attention difficulties, anxiety, depression, or any other neurological or psychiatric condition.
This listing exists to demonstrate correct disclosure. It is not an offer, and no clinical program is available behind it.
How it may work
Semax is described in published literature as a peptide related to a fragment of adrenocorticotropic hormone, studied in limited settings.
Study outside the United States does not establish FDA approval, and ClientRx does not import claims from other regulatory systems.
No dosing or administration guidance is provided.
Safety summary
- The human safety profile in an unsupervised setting is not established.
- Products marketed as research chemicals are not manufactured to pharmaceutical standards.
- Anyone experiencing neurological or psychiatric symptoms should seek evaluation from a licensed clinician rather than self-treating.
This summary is not a complete list of risks and is not medical advice. Visit the safety center. In an emergency, call 911.
Program questions
ClientRx makes no cognitive claim. Such claims are common online and are not supported by FDA-approved evidence.
Related programs
Peptide Programs
BPC-157
An investigational peptide displayed for demonstration purposes with a strong regulatory disclosure.
$199/month
All-inclusive program price · Illustrative demonstration pricing
Peptide Programs
CJC-1295
An investigational growth-hormone-releasing peptide shown with a full regulatory disclosure and no outcome claims.
$199/month
All-inclusive program price · Illustrative demonstration pricing